Patient-Centered Medication Adherence Intervention for Schizophrenia (AMAIS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00144027|
Recruitment Status : Completed
First Posted : September 2, 2005
Results First Posted : December 23, 2014
Last Update Posted : April 24, 2015
|Condition or disease||Intervention/treatment||Phase|
|Schizophrenia||Behavioral: Antipsychotic medication adherence intervention||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||75 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Patient-Centered Medication Adherence Intervention for Schizophrenia|
|Study Start Date :||December 2004|
|Actual Primary Completion Date :||June 2009|
|Actual Study Completion Date :||July 2009|
No Intervention: Control
The control group will receive treatment as usual; meaning patients in the control group will not receive the medication adherence intervention.
Experimental: Antipsychotic adherence intervention
Antipsychotic Medication Adherence Intervention which included the Barriers, Facilitators, and Motivators Checklist summary and Adherence tips provided in hard copy to patient and electronic copy to mental health provider.
Behavioral: Antipsychotic medication adherence intervention
The medication adherence intervention will include using a computer to complete a brief set of questions related to medication adherence before mental health clinic visits.
- Antipsychotic Medication Adherence [ Time Frame: 6-months ]The self-report adherence measure asked patients to think about the past four weeks and report to what extent they took their medication for mental, emotional, or nervous problems and report the result on a 5-point Likert scale ranging from 'I never missed taking my medicine' to 'I stopped taking the medicine altogether'. Patients who received depot injections were asked to think about the past six months. Self-report adherence was defined as 1=I never missed taking my medicine' and 0=any other response to the medication adherence question.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00144027
|United States, Arkansas|
|Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR|
|No. Little Rock, Arkansas, United States, 72114-1706|
|Principal Investigator:||Jeffrey M. Pyne, MD||Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR|